(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Fundamentals and Regulatory
- New chapter in the European Pharmacopeia on high-throughput sequencing for the detection of viral extraneous agents
- Enhancing Viral Safety: Prior knowledge and platform virus clearance strategies in the era of ICHQ5A (R2)
- Implications of the ICHQ5A (R2) on viral clearance studies scopes
Nanofiltration of challenging plasma derived proteins
- Robustness study of Planova S20N
- Evaluation of Planova S20N with IVIG solution
- Visualizing Virus Retention in Planova Filter Membranes
Rapid nanofiltration enabling highly efficient processing
- Evaluation of Planova FG1 virus filter: enhancing efficiency and addressing filterability challenges in a diverse therapeutic antibody pipeline
- Evaluation of Planova S20N and Planova FG1 with a mAb solution
- Evaluation of Planova FG1 on multiple proteins and virus removal results
Cell Culture Clarification with Tangential Flow Microfiltration
- Evaluation of BioOptimal UMP in a perfusion production
- Intensification strategies for Adeno Associated Virus (AAV) production processes
- Optimizing TFF hollow fiber filtration for scalable perfusion bioprocessing
New Trends and Applications
- Media nanofiltration for Advanced Therapy Medicinal Products (ATMP)
- Implementation of Planova 35N in a new gene therapy production process
- Continuous nanofiltration with Planova S20N
© Copyright 2025 Asahi Kasei